Role of intranasal fluticasone furoate spray in modifying quality of life of children with adenoid hypertrophy

Authors

  • Md Mazharul Islam Assistant Professor, Department of ENT, Rangpur Medical College Hospital
  • AKM Rezaul Karim Senior Consultant, Department of ENT, Rangpur Medical College Hospital
  • Md Ahsanul Habib Assistant Professor, Department of ENT, Rangpur Medical College Hospital
  • Nafisa Zaman Resident (MD course), Department of paediatrics.Rangpur Medical college Hospital
  • Md Tanvir Hasan Intern Doctor, Rangpur Medical College Hospital

DOI:

https://doi.org/10.3329/bjo.v24i1.45330

Keywords:

Adenoid hypertrophy, Topical steroids, Fluticasone furoate,OSA-18Questionnaire

Abstract

Introduction: Symptoms of adenoid hypertrophy is commonly seen among the pediatric age group. Since the surgical approach for this on immunity is controversial, the study was planned out to appraise the outcome of intranasal Fluticasone Furoate spray use.

Objective:To find out the efficacy of Fluticasone Furoate nasal spray in reducing clinical symptoms due to enlarged adenoid.

Methods: The prospective observational study was conducted in the Rangpur Medical College Hospital between April 2017 to August 2017 among 64 patients aged 4-15 years. Improvement on clinical symptoms was assessed by the structured OSA-18 questionnaire.

Results: At the end of 4 weeks, statistically significant improvement (p < 0.001) was observed in nearly all the domains of among the 64 participants. The average total score showed improvement from 60.95 to 46.37.

Conclusion:The use of fluticasone furoate nasal spray considered to be useful in reducing clinical symptoms of adenoid hypertrophy among children.

Bangladesh J Otorhinolaryngol; April 2018; 24(1): 22-28

Downloads

Download data is not yet available.
Abstract
30
PDF
71

Downloads

Published

2020-02-04

How to Cite

Islam, M. M., Karim, A. R., Habib, M. A., Zaman, N., & Hasan, M. T. (2020). Role of intranasal fluticasone furoate spray in modifying quality of life of children with adenoid hypertrophy. Bangladesh Journal of Otorhinolaryngology, 24(1), 22–28. https://doi.org/10.3329/bjo.v24i1.45330

Issue

Vol. 24 No. 1 (2018)

Section

Original Articles

License

Manuscripts submitted for publication in the Bangladesh Journal of Otorhinolaryngology must not have been previously submitted or published. Accepted papers become the permanent property of the Bangladesh Journal of Otorhinolaryngology. By submitting a manuscript, the authors(s) agree that copyrights for their articles are automatically transferred to Bangladesh Journal of Otorhinolaryngology, if and when the articles are accepted for publication.

The use, in this journal, of registered trade names, trade marks, etc. without special acknowledgement does not imply that such names, as defined by the relevant protection laws, be regarded as unprotected, and, thus, free for general use.

Authors who publish with this journal agree to the following terms:

 

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).